SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

The findings could make the case for prioritising blood pressure control as people age, given that there is no known cure for ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with ...

A directive in January from the National Institutes of Health aimed to reduce funding for many of the essential costs that ...

The outlook on the prevention, diagnosis and treatment of Alzheimer’s disease is brighter than ever. Backed by decades of ...

Eli Lilly has requested Europe's drug regulator to re-examine its opinion on the company's Alzheimer's drug, the agency said ...